Literature DB >> 16804046

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

Wouter J K Hehenkamp1, Caspar W N Looman, Axel P N Themmen, Frank H de Jong, E R Te Velde, Frank J M Broekmans.   

Abstract

CONTEXT: Anti-Müllerian hormone (AMH), a quantitative marker for ovarian reserve, has been suggested to be independent of the classical endocrine fluctuations of the menstrual cycle.
OBJECTIVE: The objective of the study was to determine whether AMH levels are constant throughout the menstrual cycle, compared with those of FSH, LH, and estradiol. DESIGN/PATIENTS: Frequent blood sampling was performed in 44 fertile, regularly cycling, female volunteers during one full menstrual cycle.
SETTING: The study was conducted at a university hospital. MAIN OUTCOME MEASURES: AMH, FSH, LH, and estradiol measurements were allocated to one of seven cycle phases, and a multilevel analysis was performed. Consistent fluctuation patterns were tested by fitting sine patterns to the data. Finally, the frequency in which randomly selected individual samples would remain in one of five preset level categories (quintiles) for each of the variables was studied.
RESULTS: A sine pattern fitted to the AMH data was not statistically significant (P = 0.40). In contrast, sine patterns for FSH, LH, and estradiol were highly significant. Comparing the seven cycle phases, no significant differences could be observed between phase-specific AMH levels (P = 0.06). Repeated selection of AMH samples for each individual showed that in 71.5% of selections, AMH values remained in the same quintile, whereas in 27.9% values fell in an adjacent quintile.
CONCLUSIONS: AMH levels measured through a full menstrual cycle did not show consistent fluctuation patterns in contrast to levels of FSH, LH, and estradiol. Furthermore, random fluctuations were small, indicating that AMH can be relied on as a cycle-independent marker for ovarian reserve.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804046     DOI: 10.1210/jc.2006-0331

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  104 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Authors:  Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2018-02-08       Impact factor: 7.396

Review 3.  Ovarian reserve evaluation: state of the art.

Authors:  Bruno Ramalho de Carvalho; Ana Carolina Japur de Sá Rosa e Silva; Júlio César Rosa e Silva; Rosana Maria dos Reis; Rui Alberto Ferriani; Marcos Felipe Silva de Sá
Journal:  J Assist Reprod Genet       Date:  2008-08-05       Impact factor: 3.412

4.  Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Müllerian hormone versus small antral follicle count (2-6 mm).

Authors:  Abbas Aflatoonian; Homa Oskouian; Shahnaz Ahmadi; Leila Oskouian
Journal:  J Assist Reprod Genet       Date:  2009-06-20       Impact factor: 3.412

5.  Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.

Authors:  Katherine Cameron; Mary D Sammel; Maureen Prewitt; Clarisa Gracia
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

6.  Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.

Authors:  J K Kline; A M Kinney; B Levin; A C Kelly; M Ferin; D Warburton
Journal:  Hum Reprod       Date:  2011-04-05       Impact factor: 6.918

7.  Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

Authors:  Nikolaos Perakakis; Jagriti Upadhyay; Wael Ghaly; Joyce Chen; Pavlina Chrysafi; Athanasios D Anastasilakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-05-09       Impact factor: 8.694

8.  Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.

Authors:  Melissa Pawelczak; Lisa Kenigsberg; Sarah Milla; Ying-Hua Liu; Bina Shah
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

9.  Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.

Authors:  MaryFran Sowers; Daniel McConnell; Katherine Gast; Huiyong Zheng; Bin Nan; Jenifer D McCarthy; John F Randolph
Journal:  Fertil Steril       Date:  2009-12-06       Impact factor: 7.329

10.  Serum antimüllerian hormone predicts ovarian reserve in a monkey model.

Authors:  Susan E Appt; Thomas B Clarkson; Haiying Chen; Michael R Adams; Patricia J Christian; Patricia B Hoyer; Mark E Wilson; Jay R Kaplan
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.